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Pulmonary pressure and arteriolar resistance are ele-
vated in uncomplicated primary systemichypertension.
This study was carried out in 16 men with this form of
hypertension and in 9 healthy men to compare 1) their
pulmonary vascular reactivity to endogenous catechol-
amines released during mental arithmetic and cold pres-
sor tests, and 2) the dose-responserelation to exogenous
epinephrine and norepinephrine. Arithmetic and cold
pressor tests were associated, respectively, with a pre-
dominant increase in plasma epinephrine and norepi-
nephrine concentration;changesweresignificantly greater
in hypertensive men. During the two tests, pulmonary
arteriolar resistance in the normotensive group was re-
duced by 13% and augmented by 7% of baseline, re-
spectively, whereas it was raised by 31 and 70%, re-
spectively, in the hypertensive group. In normal subjects,
the dose (ILg)-response (A dynes) relation to epinephrine
was 1 = -4, 2 = -9, 3 = -9 and 4 = -10; to
Pressure in the pulmonary artery among hypertensive pa-
tients is significantly higher (1) than in normotensive in-
dividuals (2). The associated increase in vascular resistance
in the lungs (3,4) is not explained by changes of mechanical
or chemical factors that are currently involved in the pul-
monary vasomotion in humans (5).
The hypothesis has been advanced that the greater and
lesser circulations share a common primary vasoconstrictor
mechanism in hypertension (4,6), and a positive correlation
has been found between systemic and pulmonary vascular
resistance (7). In addition, stimulation of the sympathetic
nervous system through mental arithmetic and cold pressor
tests (8) in subjects with essential hypertension resulted in
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norepinephrine it was 2 = + 3, 4 = + 6, 6 = + 7 and
8 = +7. In hypertensive patients, the respective rela-
tions were 1 = + 18, 2 = +44, 3 = +59 and 4 =
+77; and 2 = +39,4= +54,6= +76 and 8 = +98.
Group differences were highly significant. In each of
these circumstances, the driving pressure across the lungs
was significantly augmented in the hypertensive but not
the normotensive group.
Both epinephrine and norepinephrine have a
vasoconstrictor influence on the lesser circulation as a
consequence of vascular overreactivity. The opposite
changes in resistance between normotensive and hyper-
tensive subjects produced by epinephrine suggest that a
constrictor vascular supersensitivity becomes active in
the pulmonary circuit with the development of systemic
high blood pressure.
(J Am Coli Cardiol1986;8:1l37-44)
increases in blood pressure and vascular resistance in the
lung which were undetectable or much less pronounced in
normotensive individuals. Although these findings sug-
gested a neurally mediated pulmonary vascular overreactiv-
ity (9), the exaggerated responses to stress could either be
a primary alteration in smooth muscle sensitivity (abnor-
malities of vascular receptors or excitation-contraction cou-
pling) or organ structure (increased wall thickness and lumen
encroachment). They could also reflect abnormal levels of
external activation (autonomic nervous system or other reg-
ulatory components). These points were considered of
pathophysiologic importance, and the present study was
intended to contribute to their clarification.
Methods
Study subjects. Sixteen hypertensive men (mean age
45 ± 3.8 years; mean weight 73 ± 6 kg) and nine healthy
normotensive men (mean age 47 ± 4.6 years; mean weight
71 ± 5.2 kg) had mental arithmetic and cold pressor tests
as well as epinephrine and norepinephrine infusions. All
0735-1097/86/$3.50
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subjects underwent testing in the hospital. Hypertensive in-
dividuals showed repeated supine diastolic pressure readings
between 95 and 110 mm Hg and had never received anti-
hypertensive therapy. None of them had priority need for
treatment, evidence of cardiac, lung or cerebrovascular dis-
ease or an underlying renal or endocrine cause of hyper-
tension . Respiratory gases and pH of the arterial blood were
normal, and symptoms or signs referable to sleep apnea
syndrome (10) were absent. Normoten sive men were sub-
jects with atypical chest pain in whom coronary disease was
excluded by angiography . They were not undergoing any
form of treatment. The scientific purposes of the program
and the investigative procedures were explained in detail to
each patient.
Hemodynamic procedures. For the right-sided pressure
and cardiac output measurements, a triple lumen 7F ther-
modilution balloon-tipped catheter (Edwards Laboratories)
was inserted percutaneously into an antecubital vein and
advanced to the pulmonary artery or. when necessary , to
the pulmonary wedge position. Systemic arterial pressure
was derived from the right brachial artery through insertion
of a Teflon catheter needle . Endovascular procedures were
accomplished under local anesthesia. Pressures were deter-
mined with Statham strain gauge transducers, with the zero
reference levelS em below the sternal angle . The pulmonary
artery wedge pressure was characterized by a distinct A and
V waveform , with the V wave occurring after the T wave
on the electrocardiogram. Cardiac output was determined
by the thermodilution method. Systemic vascular resistance
(SVR) and pulmonary arteriolar resistance (PAR) were de-
rived from the following formulas : SVR = (AP - RAP
x 1332 x 60)/CO (ml/min) ; PAR = (PP - PWP x 1332
x 60)/CO (mllmin), where AP, RAP, PP and PWP are,
respectively, mean systemic , right arterial, pulmonary and
pulmonary wedge pressures and CO is cardiac output. The
circulatory variables and pleural pressure, estimated by the
method of Milic-Emili et al. (11) , were recorded on the
same record ing system (Gould-Brush eight channel re-
corder, model 480). Arterial oxygen and carbon dioxide
tension and pH were determined by methods reported pre-
viously (4) .
Physiologic and pharmacologic tests. Most of the test-
ing sessions occurred in the morning, I week after admission
to the hospital and after the patients had been familiarized
on 3 consecutive days with the investigators, equipment
expert and environment. They were instructed not to smoke
or ingest alcohol or caffeine-containing foods for 24 hours
before testing . After the subjects had been supine for at least
30 minutes, blood samples (10 ml) were drawn through the
intraarterial needle for catecholamine and blood gas deter-
minations. Thereafter, they were subjected to mental arith-
metic (division over a period of 2 minutes of a four digit
number by a two digit number while under the pressure of
time) and cold stimulation (the standard cold pressor test of
3 minutes' duration) (8). The two stressful tests were al-
ternated and repeated twice in each patient at 10 minute
intervals . Averages of the two measurements were taken as
the representative value for the subject.
After a 20 minute rest period, the subjects received (through
the proximal port of the venous catheter placed at the level
of the right atrium) infusion of epinephrine (8 p.g/ml in 5%
dextrose in water) or norepinephrine (16 p.g/ml in 5% dex-
trose in water) at initial doses of 0 .5 and I p.g/min for 3
minutes, respectively . These drugs were infused in random
order. The infusion doses were increased (different speed
with a constant infusion pump) in doses of I , 2, 3 and 4
p.g/min and of 2, 4, 6, and 8 p.g/min, respectively, with a
minimallS minute washout period between each infusion
until there was an increase in systolic blood pressure similar
to that attained during the mental arithmetic and cold stim-
ulation tests , respecti vely , or tachycardia of 30 beats/min
was observed. The reason for this was to contain the pressure
reaction to pharmacologic tests in the hypertensi ve subjects
within the limits of response to physiologic stimuli. In most
instances these effects were obtained with the largest doses
just indicated . In three hypertensive subjects, the upper ar-
bitrary limit of the circulatory reaction was reached with
intermediate doses. Continuous records of heart rate (car-
diotachograph) and pleural, aortic and pulmonary pressures
were obtained throughout the studies . Cardiac output and
pulmonary wedge pressure were measured, and systemic
and pulmonary arteriolar resistance were calculated at base-
line and during the largest pressure variations . These were
generally recorded at the end of each phase. At the same
periods during physiologic stimuli, arterial blood sampling
was repeated for measurement of plasma epinephrine and
norepinephrine concentrations and during both physiologic
and pharmacologic tests for assessment of the respiratory
gases and pH.
Plasma catecholamine concentration was evaluated by
high performance liquid chromatography with electrochem-
ical detection (12).
Statistical analysis. Data obtained at baseline study and
at the end of each phase were expressed as mean ± SD.
Statistical analysis was carried out using either one-way or
two-way analysis of variance as appropriate. Dose-re-
sponses were tested for significance by a one-tailed t test.
Results
The two patient groups were well matched for age and
somatic characteristics. Baseline pleural pressure , arterial
oxygen and carbon dioxide tension and pH were similar to
normal in the hypertensive men, and in neither group did
they change significantly during stressful stimulations or
catecholamine infusions.
Responses to physiologic stimuli. Averages of the cir-
culatory variables and epinephrine and norepinephrine plasma
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concentrations at baseline and at the moment of maximal
pressure reaction to the mental arithmetic and cold pressor
tests are illustrated in Figure I . Plasma concentrations of
epinephrine and norepinephrine were higher in the hyper-
tensive group in the steady state and were augmented during
both stimuli. The increase in epinephrine was more pro-
nounced during the mental test, and that of norepinephrine
was unequivocally preferential during the physical cold
stimulus. The humoral reaction was greater in the hyper-
tensive group in terms of levels reached and variations from
baseline (epinephrine response to arithmetic: normotensives
+ 19± 6 pglml, hypertensive men + 79± 12 pg/ml;
norepinephrine responses to cold: normotensive men + 33 ±
7 pg/rnl, hypertensive men + 85 ± II pg/ml).
The circulatory changes were the following: In the sys-
temic circulation, blood pressure increased with both stimuli
in both groups, but to a greater extent in the hypertensive
group; in both groups the systemic pressure increase during
mental arithmetic was mediated through a similar increase
in cardiac index, associated with a tendency of the vascular
resistance to decrease, while a raised systemic vascular re-
sistance (which was greater in hypertensive men) with hardly
noticeable changes in cardiac index characterized the sys-
temic hemodynamic response to cold. In the pulmonary
circuit, neither stimulus affected pressure and arteriolar re-
sistance in the normotensive control subjects, while both
stimuli augmented pulmonary systolic and diastolic pres-
sures to similar levels in the hypertensive patients; the in-
crease was mediated through increments in both flow and
resistance during mental arithmetic and exclusively through
the latter during the cold pressor test. Changes in cardiac
output occurred in parallel with those in heart rate, which
in both groups was augmented by the mental stimulus and
slightly reduced by the physical stimulus.
Responses to pharmacologic stimuli. In many respects,
the hemodynamic response of the greater and lesser circu-
lations to exogenous epinephrine (Fig . 2) and norepineph-
Figure I. Mean (± SD) hemodynamic values and plasma cate-
cholamine concentrations at baseline and during arithmetic and
cold pressor tests in the normotensive (0) and hypertensive (0)
study patients. A = arithmetic test; AP = aorticpressure (systolic
and diastolic); B = baseline; C = cold pressortest; CI = cardiac
index; E = epinephrine; HR = heart rate; NE = norepinephrine;
PAR = pulmonary arteriolarresistance; PP = pulmonary pressure
(systolic and diastolic); SVR = systemic vascular resistance;
.& = differences fromthecorresponding valuein the normotensive
groupsignificant at p < 0.0 I; *and ** = differences frombaseline
significant at p < 0.05 and < 0.0 I, respectively .
rine (Fig . 3) were qualitatively and, at the largest infusion
doses , quantitatively similar to the response recorded during
the mental arithmetic and cold pressor test, respectively.
The only qualitative difference was the slight and significant
stepwise reduction in the systolic and diastolic blood pres-
sures in hypertensive subjects during epinephrine infusion
as a result of a more substantial decrease in systemic vas-
cular resistance ( - 385 dynes at 4 JLg/min) compared with
the arithmetic test ( - 136 dynes). As specifically referred
to the pulmonary circulation, the finding was duplicated that
either compound was ineffective in normotensive subjects
and unequivocally increased pulmonary pressure and re-
sistance in hypertensive subjects.
Figure 4 is a log dose-response plot showing the increase
in systemic and pulmonary arteriolar resistance with in-
creasing doses of norepinephrine in the normotensive and
hypertensive patients. Dose-response curves in both groups
have similar-shaped configurations, but the curves for the
hypertensive group were steeper and shifted to the left.
Variations in systemic resistance of all hypertensive patients
were outside the range of values in normotensive subjects
at 6 and 8 JLg.min (p < 0.01), and variations in pulmonary
resistance at all infusion rates beyond the threshold exceeded
the normal values (p < 0.01).
Figure 5 is a log dose-response plot showing variations
of the same variables with increasing doses of epinephrine
in the same patient groups. Epinephrine had a depressor
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Figure 2. Hemodynamic responses to
scalar doses of intravenously infused
epinephrine in the normotensive and hy-
pertensive studypatients(mean ± SD).
PWP = mean pulmonary wedge pres-
sure; other abbreviations and symbols
as in Figure I.
effect on systemic vascular resistance; this was more pro-
nounced in the hypertensive group (p < 0.01 at 2, 3 and 4
JLg.min). The vasomotor influence of epinephrine on the
pulmonary bed was opposite in the two groups, arteriolar
resistance being mildly depressed in normotensive subjects
and substantially enhanced in hypertension so that differ-
ences in changes were significant (p < 0.01) at any step
beyond the threshold (0 .5 JLg.min) .
Discussion
There are two initial questions that need clarification . 1)
Do the circulatory alterations during physiologic stimuli
depend on endogenously released catecholamines and are
the responses to mental arithmetic and cold stimuli essen-
tially mediated through release of epinephrine and norepi-
nephrine , respectively? 2) Do changes in pulmonary arter-
iolar resistance during the tests in the hypertensive group
reflect active vasomotion?
Epinephrine and norepinephrine release during phys-
ical and mental stimuli. Many comparative studies have
reported higher levels of catecholamines in hypertensive
than in normotensive subjects . They have also shown that
these differences are small when blood is sampled under
quiet rest conditions , but the catecholamine response to
tests, whether physical (such as cold exposure) or psycho-
logic (such as mental arithmetic), is exaggerated in patients
with essential hypertension (13,14). In hypertension as in
normotension there is a preferential increase in plasma nor-
epinephrine during the physical stimuli and of plasma epi-
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Figure S. Systemic and pulmonary vaso-
motor responses evoked by epinephrine in
the normotensive (0) and hypertensive (0)
study patients (mean ± SO). * and ** =
differences from the corresponding value in
the normotensive subjects significant at p <
0.05 and < 0.01, respectively; abbreviations
and format as in Figure 4.
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nephrine during psychologic stimuli (13,14). On the other
hand, the documentation is unequivocal that the classic car-
diac and systemic vascular effects (15) of exogenously ad-
ministered norepinephrine are duplicated by the cold pressor
test and that those of epinephrine are in part reproduced by
the mental arithmetic test, either procedure having been
performed in the same subject in this study. The less pro-
nounced vasodilation during mental arithmetic as compared
with that during epinephrine infusion and the pressure in-
crease during the physiologic rather than the pharmacologic
stimulus in the hypertensive group were probably due to a
relative selectivity of the physiologic test, which also elic-
ited a small increase in the norepinephrine plasma concen-
tration. These considerations support a positive response to
the first question.
Pulmonary vasomotor changes during systemic hy-
pertension. Among the factors controlling the flow of blood
through the pulmonary circuit, those of mechanical origin
are predominant, and knowledge of the passive relation
between pressure and flow is essential in the interpretation
of pharmacologic or physiologic interventions that also in-
volve the heart and the systemic circuit. If this relation is
not linear, changes in resistance when flow is also changing
may not necessarily reflect an active vasomotion. The evi-
dence in the dog is that this relation is linear (16), and the
same seems true of normal human subjects in the supine
position when flow is suddenly doubled (17); the actual
passive pressure-flow relation with small changes in flow
in humans, however, is not known. In this study, the in-
crease in pulmonary blood flow promoted by the endoge-
nously released (mental arithmetic test) and exogenously
administered epinephrine slightly reduced the baseline dif-
ference between the pulmonary artery and wedge pressures
in the normotensive men while a similar increase in flow
by the same stimuli in the hypertensive men was associated
with a substantial increase in the driving pressure across the
lungs (Fig. 2). It follows that changes in pulmonary arter-
iolar resistance under the influence of endogenous (Fig. 1)
and exogenous (Fig. 5) epinephrine actually reflect an active
vasoconstriction in this group. Of particular significance is
the response to norepinephrine released during the cold pres-
sor test and to norepinephrine infused exogenously. In both
circumstances, blood flow tended to become reduced to a
similar extent in the two patient groups; however, in hy-
pertensive men, the driving pressure through the lungs be-
came as great as during the influence of epinephrine, sug-
gesting that an even greater vasomotion had occurred (Fig.
3 and 4). Respiratory factors should be considered extra-
neous to these phenomena because the measured variables
(pleural pressure, arterial blood gases and pH) were com-
parable at baseline and during the tests.
Catecholamine concentration as a reflection of neu-
rogenic vascular response. Although catecholamine con-
centrations in body fluids are utilized as indicators of the
adrenergic discharge and neural participation in essential
hypertension (18), there are good reasons to be cautious
about their application for assessing neurogenic contribu-
tions (19). Endogenous catecholamine assays in this study,
therefore, are taken as qualitative and not quantitative in-
dicators. Because of this, no inference will be drawn as to
whether the underlying mechanism of the exaggerated sys-
temic blood pressure reactivity to endogenously released
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norepinephrine does or does not reflect abnormal levels of
external (neural) vascular activation. The exogenous nor-
epinephrine tests show that the pressure reactivity is asso-
ciated with vascular overreactivity , but does not contribute
to discerning whether or not the latter derives from a specific
abnormality in vascular sensitivity.
Catecholamine concentration and pulmonary vascu-
lar overreactivity. Conclusions may be different when the
pulmonary circulation is considered. It was documented that
norepinephrine , either endogenous or exogenous , is not ap-
preciably effective on the pulmonary vascular tone in nor-
motensive individuals and that , in agreement with findings
in the cat (20), epinephrine shows a slight vasodilating ac-
tion in this group. Such an effect was unequivocal from the
dose-response curve. In marked contrast with these results,
in hypertension both catecholamines, from either source,
had a pressor and vasoconstrictor effect. The dose-response
plot showing the increase in resistance with increasing doses
of norepinephrine documents the existence of vascular over-
reactivity . Although some evidence has been reported (21)
of a tendency to increase the pulmonary artery medial thick-
ness in spontaneous hypertensive rats, there is no infor-
mation in human subjects concerning the possibility of du-
plication in the lesser circulation of the structural vascular
changes occurring in the greater circulation in hypertension
(22). The question, therefore, concerning the relation be-
tween constrictor overreactivity and structure of the pul-
monary vessels remains open . However , the observation
that, during the release of endogenous epinephrine and es-
pecially during exogenous infusion , normotensive subjects
responded with vasodilation while hypertensive patients de-
veloped substantial vasoconstriction is not in favor of in-
creased wall thickness and lumen encroachment because a
greater decrease rather than an increase in resistance would
be anticipated. This opposite vasomotor pattern suggests
that a constrictor pulmonary vascular supersensitivity be-
comes active with the development of systemic hyperten-
sion. The baseline levels of circulating catecholamines, which
were higher in hypertensive than in normotensive men, do
not seem responsible for these changes because if this was
the case , vascular responsivene ss might have even become
decreased.
Conclusions. A review of the studies concerned with
the influences of catecholamines on the lesser circulation in
humans shows an increase in the pulmonary artery and wedge
pressures under the influence of norepinephrine without re-
markable changes in arteriolar resistance and blood flow
through the lungs. The balance of evidence is against the
existence of substantial pulmonary vasoconstriction in nor-
mal humans . This pattern is interpreted as resulting from
passive vasodilation as a consequence of displacement of
blood from the periphery and some vasoconstriction caused
by stimulation of alpha-adrenergic receptors (17). On this
basis , one should deduce that in hypertension, in addition
to an impedance to the pulmonary passive dilation, there is
an enhancement of active pulmonary vasoconstriction. These
changes may derive from abnormalities in the number or
quality (23) of adrenergic receptors or other regulatory com-
ponents (24), or in the biochemistry involved in the exci-
tation-contraction coupling (7) . Were the latter mechanism
proved , then the hypothesis of a generalized membrane phe-
nomenon responsible for enhancement in vascular contrac-
tility in hypertension (25) would be reinforced on clinical
grounds.
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